HYDRAGEN
Food supplement declared in France, declaration No 2022-6-534, decision dated 8 June 2022
HYDRAGEN is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- SANTEXIA
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Capsule
- Daily dose
- 2 capsules
- Directions for use
- prendre 2 capsules par jour avec un grand verre d'eau
- Not recommended for (according to the manufacturer)
- Sous anticoagulants
Declaration 218717, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Elaeagnus rhamnoides (L.) A.Nelson | Fruit | Extrait au CO2 supercritique | 1,100 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-alpha-tocophérol | Vitamine E | 300 mg | 30 mg |
Additives
E422
Other ingredients
gélatine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière recommandée. Déconseillé aux personnes sous traitement anticoagulants
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.